Comparison of blood loss during Caesarean sections using Misoprostol placed within uterus as against placement inside rectum
Phase 3
- Registration Number
- CTRI/2024/01/062091
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Antenatal women more than 37 weeks of gestation planned for Elective LSCS
Exclusion Criteria
Fetal Anomalies
Maternal Medical disorders
Placenta previa ,Placenta accreta spectrum
Known allergy to prostaglandin
Previous 2 LSCS or more
Patients requiring blood transfusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method